Volume spike: SLHGF Skylight Health Group Inc. (PNK) sees 40,000 shares on 05 Mar 2026 — what it means
SLHGF stock jumps on a **40,000** share volume spike on 05 Mar 2026; quick financial and technical check for traders
-
-
Northland Upgrades Piper Sandler (PIPR) to Outperform Mar 4, 2026
Northland upgrades Piper Sandler to Outperform on Mar 4, 2026; PIPR analyst rating shifts with $350 price target
-
CARGOSOL.BO (BSE) drops to INR 25.06 on 05 Mar 2026: watch for oversold bounce
Intraday oversold bounce view on CARGOSOL.BO stock at INR 25.06 on BSE with technical triggers and Meyka AI forecast
-
ALMII.PA Maison Internationale de l’Informatique EURONEXT 05 Mar 2026: Oversold bounce at €8.45, 50-day trend test
ALMII.PA stock trades at €8.45 on EURONEXT intraday; analyst view on oversold bounce, valuation, and Meyka AI forecast
-
Solana USD Faces Critical $95 Test as 6.40% Daily Gain Stalls
SOL trades at $91.29 with 6.40% daily gains. Technical analysis reveals key resistance at $95 and support at $75.89 as Solana USD navigates volatile conditions.
-
Japan E-Scooter Crackdown March 5: First Case for Skipping Safety Course
Japan e-scooter regulation tightens as Tokyo police file first case for refusing a mandatory driver course, signaling higher compliance risks for operators and insurers.
-
Close: 7980.T Shigematsu Works (JPX) down 13.44% on volume spike: watch liquidity and outlook
Volume spike at close pushes 7980.T stock down 13.44% on JPX; high volume, valuation and Meyka AI forecast analysed
-
HK$0.188: Tong Tong AI (0628.HK) HKSE after-hours AI stock signals valuation gap
After-hours look at 0628.HK stock at HK$0.188; PE 18.80, Meyka AI forecast and targets for HKSE investors
-
DBAN.DE Deutsche Beteiligungs XETRA €24.80 Mar 2026: earnings to test dividend
DBAN.DE stock intraday earnings spotlight. Price €24.80, earnings 10 Mar 2026, dividend and guidance key
-
Texas Election Results March 05: Trump Endorsement Looms in GOP Runoff
Texas election results Texas set a May 26 GOP runoff between John Cornyn and Ken Paxton as Trump eyes an endorsement. What it means for policy, donors, and markets.
